CANCER BIOLOGY
 
  
 
 
Definition 
 
 

 

 

 

 

 

 

 

 

 

 

 

  

 
Terms 
Adenocarcinoma 
 
 
 
 
Adenoma 
 
 
 
Ames test 
 
 
 
 
Aneuploidy 
 
 
 
Angiogenesis 
 
 
Anti- angiogenesis
 
Therapy 
 
 
  
Anti- telomerase 
 
Therapy 
 
 
  
Apoptosis 
 
 
Bacterial mutagenesis
 
 
test 
 
 
Basement membrane 
 
 
 
 
Bcl2 
 
 
 
Bcr - abl gene 
 
   
 
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BCR-ABL protein 
 
 
 
 
 
Benign tumor 
 
 
 
Benzo(a)pyrene(B(a)P) 
 
 
 
Biomarkers 
 
 
 
Breast cancer 
 
 
 
 
Cancer Diagnosis 
 
 
 
 
Cancer invasion 
 
 
 
 
Cancer prevention 
 
 
 
 
Cancer therapeutics 
 
 
 
 
Carcinogenic 
 
 
 
Carcinogenicity test 
 
 
 
 
Carcinoma 
 
 
 
Carcinogens 
 
 
 
 

 

 
2
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cell cycle arrest 
 
 
 
 
 
 
Chemoprevention 
 
 
 
Chemotherapy 
 
 
 
Chemotherapy side-
effects 
 
 
Chromosomal 
 
 
translocation 
 
 
Chromosomal 
 
abnormalities 
 
Chromosomal 
 
 
deletions 
 
Chromosomal 
 
 
duplications 
 
Chromosomal 
 
segregation defects 
 
 
 
Chronic Myeloid
 
 
 
 
leukemia (CML) 
 
 
Cisplatin 
 
 
 
Clinical relapse 
 
 
 
 
Clinical remission 
 
 
 
 
 

 

 
3
 

 

 

 
Clonal evolutionary
 
theory 
 
 
Colon cancer 
 
 
 
 
Conventional cancer 
 
therapies 
 
 
 
de novo mutations 
 
 
 
 
 
Deletion 
 
 
DNA damaging
 
 
agents 
 
 
DNA repair defects 
 
 
 
 
 
DNA strand breaks 
 
 
 
 
 
Exogenous mutagen 
 
 
 
Familial cancer 
 
 
 
syndromes 
 
 
Familial 
 
predisposition 
 
Gain of function 
 
 
 
 
(dominant mutation) 
 
Gardisal 
 
 
 
Gene activation 
 
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

 

 
4
 

 
 

 

 

 

 

 

 

 

 

 

 

 

 
Gene amplification 
 
 
 
Gene therapy 
 
 
 
 
Gleevac 
 
 
 
 
Growth factor 
 
receptor 
 
Her2 gene
 
 
 
amplification 
 
 
Herceptin 
 
 
 
H-ras 
 
 
Human papilloma
 
 
virus 
 
 
Hyperplasia 
 
 
 
Immortal cells 
 
 
Immuno-
 
compromised mice 
 
 
 
 
Immunotherapy 
 
 
Inactivating
 
mutations (recessive:
 
 
 
 
 
stop codon mutations,
 
 
frame shift mutations,
 
deletion) 
 
 

 

 

 
5
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Incomplete
penetrance 
 
 
 
Kinase inhibitors 
 
 
 
Leukemia /
   
lymphoma 
 
 
 
Loss of heterozygosity 
 
 
 
 
 
Malignant 
 
 
 
Metastasis 
 
 
Microtubule 
 
 
inhibitors 
 
 
Mitotic recombination 
 
 
 
 
Mutagenicity assays 
 
 
 
 
Mutagens 
 
 
 
Mutation frequency 
 
 
 
 
Myc 
 
 
 
Oncogenes 
 
 
 
 

 

 
6
 

Ovarian cancer 
 
 
 
 
 
P53 
 
 
Personalized 
medicine 
 
 
 
Pro- mutagen 
 
 
 
 
Prognosis 
 
 
 
Proto- oncogene 
 
 
 
 
Radiation therapy 
 
 
 
 
Ras 
 
 
Regulated /
   
unregulated cell
division 
 
 
 
Retinoblastoma 
 
 
 
Retrovirus 
 
 
 
Sarcoma 
 
 
 
Sporadic cancer 
 
 
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
7
 

 

 

 

 

 

 

 

 

 

 

 

 

 

Structural mutations 
 
 
 
 
 
Taxol 
 
 
 
Telomerase 
 
 
 
Telomeres 
 
 
 
Therapeutic window 
 
 
 
 
Transcription factor 
 
 
 
Transformed cells 
 
 
 
Translocation 
 
 
 
Tumor cell lines 
 
 
 
 
 
Tumor immunology 
 
 
 
Tumor suppressor 
 
 
 
genes 
 
 
Tumorigenic 
 
 
 
Vaccines 
 
 
 
 

 

 
8
 

MIT OpenCourseWare
http://ocw.mit.edu

7.013 Introductory Biology
Spring 2013

For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms .

